PAVmed (PAVM) Net Shares Issued and Repurchased (2016 - 2025)

PAVmed has reported Net Shares Issued and Repurchased for 10 years, with the latest figure at $27201.0 in Q4 2025.

• On a quarterly basis, Net Shares Issued and Repurchased rose 293.02% year-over-year to $27201.0 in Q4 2025; TTM through Dec 2025 was $27201.0, a 293.02% increase from a year earlier, with the FY2025 full-year figure at $27201.0, up 293.02% from the prior year.
• Net Shares Issued and Repurchased was $27201.0 for Q4 2025 at PAVmed, down from $496928.0 in the prior quarter.
• The five-year high for Net Shares Issued and Repurchased was $7.3 million in Q1 2023, with the low at $6921.0 in Q4 2024.
• Average Net Shares Issued and Repurchased over 5 years is $2.3 million, with a median of $2.6 million recorded in 2021.
• The sharpest annual moves came in 2022 and 2024: Net Shares Issued and Repurchased soared 788.39% in 2022, then tumbled 99.81% in 2024.
• Over 5 years, Net Shares Issued and Repurchased stood at $2.9 million in 2021, then slipped by 18.45% to $2.4 million in 2022, then soared by 52.98% to $3.6 million in 2023, then plunged by 99.81% to $6921.0 in 2024, then jumped by 293.02% to $27201.0 in 2025.
• The last three Net Shares Issued and Repurchased figures came in at $27201.0 (Q4 2025), $496928.0 (Q1 2025), and $6921.0 (Q4 2024), per Business Quant data.